Search

Susan B Acton

from Wellington, FL
Age ~81

Susan Acton Phones & Addresses

  • 12576 Mallet Cir, Wellington, FL 33414 (561) 795-6574
  • 12600 Mallet Cir, Wellington, FL 33414 (561) 792-4451
  • West Palm Beach, FL
  • 269 Atlantic Ave, Cohasset, MA 02025 (781) 383-6689
  • 239 Atlantic Ave, Cohasset, MA 02025
  • Onset, MA
  • Hilton Head Island, SC
  • Hingham, MA
  • Aiken, SC
  • Palm Beach, FL
  • Concord, MA
  • Hull, MA
  • 269 Atlantic Ave, Cohasset, MA 02025 (781) 724-6751

Work

Position: Service Occupations

Education

Degree: Bachelor's degree or higher

Business Records

Name / Title
Company / Classification
Phones & Addresses
Susan B. Acton
Managing
The Cohasset Group, LLC
269 Atlantic Ave, Cohasset, MA 02025
2316 Las Casitas Dr, West Palm Beach, FL 33414
Susan Acton
Secretary
Chukker Cove Home Owners Association, Inc
3461 Fairlane Farms Rd, West Palm Beach, FL 33414
Susan B. Acton
President, Treasurer, Director
SUSAN B. ACTON INTERIORS, INCORPORATED
Interior Designers
269 Atlantic Ave, Cohasset, MA 02025
PO Box 137, Cohasset, MA 02025
369 Atlantic Ave, Cohasset, MA 02025
(781) 383-1820

Publications

Isbn (Books And Publications)

Beauty Makeover Guide

View page
Author

Susan Acton

ISBN #

0812825373

Us Patents

Class Bi And Ci Scavenger Receptors

View page
US Patent:
6350859, Feb 26, 2002
Filed:
Feb 2, 1999
Appl. No.:
09/241581
Inventors:
Monty Krieger - Needham MA
Susan L. Acton - Lexington MA
Attilio Rigotti - Santiago, CL
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
C07K 1628
US Classification:
53038822
Abstract:
Two distinct scavenger receptor type proteins having high affinity for modified lipoproteins and other ligands have been isolated, characterized and cloned. HaSR-BI, an AcLDL and LDL binding scavenger receptor, which is distinct from the type I and type II macrophage scavenger receptors, has been isolated and characterized and DNA encoding the receptor cloned from a variant of Chinese Hamster Ovary Cells, designated Var-261. dSR-CI, a non-mammalian AcLDL binding scavenger receptor having high ligand affinity and broad specificity, was isolated from The isolated receptors are useful in screening for drugs that inhibit uptake of cholesterol in endothelial or adipose cells or macrophages, respectively. They are also useful as probes for the isolation of other lipoprotein receptors and in research the roles of these receptors.

Class Bi And Ci Scavenger Receptors

View page
US Patent:
6429289, Aug 6, 2002
Filed:
Jun 23, 1994
Appl. No.:
08/265428
Inventors:
Monty Krieger - Needham MA
Susan L. Acton - Somerville MA
Alan M. Pearson - Somerville MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
C07K 14705
US Classification:
530350, 514 2
Abstract:
Two distinct scavenger receptor type proteins having high affinity for modified lipoproteins and other ligands have been isolated, characterized and cloned. HaSR-BI, an AcLDL and LDL binding scavenger receptor, which is distinct from the type I and type II macrophage scavenger receptors, has been isolated and characterized and DNA encoding the receptor cloned from a variant of Chinese Hamster Ovary Cells, designated Var-261. dSR-CI, a non-mammalian AcLDL binding scavenger receptor having high ligand affinity and broad specificity, was isolated from. The isolated receptors are useful in screening for drugs that inhibit uptake of cholesterol in endothelial or adipose cells or macrophages, respectively. They are also useful as probes for the isolation of other lipoprotein receptors and in research the roles of these receptors.

Csaptp Protein Molecules And Uses Therefor

View page
US Patent:
6436685, Aug 20, 2002
Filed:
Dec 28, 1998
Appl. No.:
09/221448
Inventors:
Susan L. Acton - Lexington MA
Assignee:
Millennium Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C12N 916
US Classification:
435196, 435 6, 4352523, 4353201, 43525411, 536 232
Abstract:
The invention provides isolated nucleic acid molecules, designated CSAPTP nucleic acid molecules, which encode novel protein tyrosine phosphatases. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing CSAPTP nucleic acid molecules, host cells into which the expression vectors have been introduced, and methods for producing CSAPTP polypeptides.

Angiotensin Converting Enzyme Homolog And Therapeutic And Diagnostic Uses Therefor

View page
US Patent:
6610497, Aug 26, 2003
Filed:
Sep 29, 1999
Appl. No.:
09/407427
Inventors:
Susan L. Acton - Lexington MA
Keith Earl Robison - Wilmington MA
Frank Y. Hsieh - Lexington MA
Assignee:
Millennium Pharmaceuticals, Inc. - Cambridge MA
International Classification:
G01N 3353
US Classification:
435 71, 436 86, 436501, 530313
Abstract:
The present invention relates to the discovery of novel genes encoding an angiotensin converting enzyme, Angiotensin Converting Enzyme-2 (ACE-2). The invention provides therapeutics, prognostic and diagnostics methods for treating blood pressure related disorders as well as various types of allergic conditions, among others. Also disclosed are screening assays for identifying compounds for treating and preventing these conditions.

Ace-2 Inhibiting Compounds And Methods Of Use Thereof

View page
US Patent:
6632830, Oct 14, 2003
Filed:
Apr 28, 2000
Appl. No.:
09/561759
Inventors:
Susan L. Acton - Lexington MA
Timothy D. Ocain - Framingham MA
Alexandra E. Gould - Cambridge MA
Natalie A. Dales - Arlington MA
Bing Guan - Brighton MA
James A. Brown - Framingham MA
Assignee:
Millennium Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A61K 31194
US Classification:
514365, 514400, 514406, 514561, 514567, 548204, 5483391, 5483395, 5483751, 562443, 562445, 562568
Abstract:
ACE-2 inhibiting compounds are disclosed. These compounds include compounds of formula (IV): wherein the variables are as described in the specification. Pharmaceutical compositions containing the compounds are also discussed. The pharmaceutical compositions may contain an effective amount of a compound of the invention to treat ACE-2 associated disorders such as a blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder.

Cardiovascular System Associated Protein Kinase 2 (Csapk-2) Antibodies

View page
US Patent:
6740737, May 25, 2004
Filed:
Jan 10, 2001
Appl. No.:
09/757982
Inventors:
Susan L. Acton - Lexington MA
Assignee:
Millennium Pharamceuticals, Inc. - Cambridge MA
International Classification:
C07K 1600
US Classification:
5303871, 53038826, 5303879, 5303873, 5303891
Abstract:
The invention provides isolated nucleic acids molecules, designated CSAPK nucleic acid molecules, which encode novel protein kinases. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing CSAPK nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a CSAPK gene has been introduced or disrupted. The invention still further provides isolated CSAPK proteins, fusion proteins, antigenic peptides and anti-CSAPK antibodies. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.

Angiotensin Converting Enzyme Homolog And Uses Therefor

View page
US Patent:
6884771, Apr 26, 2005
Filed:
Aug 9, 2000
Appl. No.:
09/635501
Inventors:
Susan Acton - Lexington MA, US
Keith E. Robison - Wilmington MA, US
Frank Y. Hsieh - Lexington MA, US
Assignee:
Millennium Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A51K038/00
US Classification:
514 2, 514 12, 530350, 530361, 424 941, 424 946, 435183, 435195
Abstract:
The present invention relates to the discovery of novel genes encoding an angiotensin converting enzyme, Angiotensin Converting Enzyme-2 (ACE-2). The invention provides therapeutics, prognostic and diagnostics methods for treating blood pressure related disorders as well as various types of allergic conditions, among others. Also disclosed are screening assays for identifying compounds for treating and preventing these conditions.

Angiotensin Converting Enzyme Homolog And Therapeutic And Diagnostic Uses Therefor

View page
US Patent:
6989363, Jan 24, 2006
Filed:
Sep 30, 1998
Appl. No.:
09/163648
Inventors:
Susan L. Acton - Lexington MA, US
Keith Earl Robison - Wilmington MA, US
Frank Y. Hsieh - Lexington MA, US
Assignee:
Millennium Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C07K 14/00
C07K 14/435
US Classification:
514 2, 530316, 530350
Abstract:
The present invention relates to the discovery of novel genes encoding an angiotensin converting enzyme, Angiotensin Converting Enzyme-2 (ACE-2). The invention provides therapeutics, prognostic and diagnostics methods for treating blood pressure related disorders as well as various types of allergic conditions, among others. Also disclosed are screening assays for identifying compounds for treating and preventing these conditions.
Susan B Acton from Wellington, FL, age ~81 Get Report